Skip to content
GenoLensGenoLens

F12

Chr 5q35.3

coagulation factor XII

MANE:
ENST00000253496.4

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bleeding and platelet disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • COVID-19 research

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Inherited bleeding disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Vascular skin disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • congenital factor XII deficiency

    0.81
  • hereditary angioedema type 3

    0.78
  • Reduced factor XII activity

    0.74
  • hereditary angioedema

    0.68
  • peptic ulcer disease

    0.45
  • angioedema

    0.41
  • flatulence

    0.37
  • serum lipopolysaccharide activity

    0.36
  • coronary artery calcification

    0.36
  • Hyperbilirubinemia

    0.34

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Coagulation factor XII

Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then trypsin cleaves it to beta-factor XIIa. Alpha-factor XIIa activates factor XI to factor XIa (PubMed:2019570, PubMed:21304106, PubMed:8427954)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.